Fragile X Syndrome in Pediatric ID: Case Discussion | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Case Discussion ](https://mdster.com/blog?category=case-discussion) 4. Fragile X Syndrome in Pediatric Intellectual Disability: Case Discussion [ Case Discussion ](https://mdster.com/blog?category=case-discussion) Fragile X Syndrome in Pediatric Intellectual Disability: Case Discussion ========================================================================== A board-style pediatrics case discussion on phenotyping, first-tier testing, and family counseling in 2026 practice. [ MDster Editorial Team ](https://mdster.com/about) · May 05, 2026 · 6 min read · 107 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Board Review ](https://mdster.com/blog?tag=board-review) [ Pediatrics ](https://mdster.com/blog?tag=pediatrics) [ Fragile X Syndrome ](https://mdster.com/blog?tag=fragile-x-syndrome) [ Intellectual Disability ](https://mdster.com/blog?tag=intellectual-disability) [ Developmental Delay ](https://mdster.com/blog?tag=developmental-delay) ![Fragile X Syndrome in Pediatric Intellectual Disability: Case Discussion](https://mdster.com/storage/blog/images/fragile-x-syndrome-in-pediatric-intellectual-disability-case-discussion.jpg) Share this article Share this post On this page 1. [ Why this phenotype should push Fragile X up the list ](#why-this-phenotype-should-push-fragile-x-up-the-list) 2. [ Workup strategy: broad enough, but not indiscriminate ](#workup-strategy-broad-enough-but-not-indiscriminate) 3. [ Why the molecular diagnosis matters ](#why-the-molecular-diagnosis-matters) 4. [ Management after Fragile X is confirmed ](#management-after-fragile-x-is-confirmed) 5. [ Clinical Application ](#clinical-application) 6. [ Key Points for Board Exams ](#key-points-for-board-exams) 7. [ Conclusion ](#conclusion) 8. [ Frequently Asked Questions ](#blog-faqs) 9. [ References ](#references-heading) On this page 1. [ Why this phenotype should push Fragile X up the list ](#why-this-phenotype-should-push-fragile-x-up-the-list) 2. [ Workup strategy: broad enough, but not indiscriminate ](#workup-strategy-broad-enough-but-not-indiscriminate) 3. [ Why the molecular diagnosis matters ](#why-the-molecular-diagnosis-matters) 4. [ Management after Fragile X is confirmed ](#management-after-fragile-x-is-confirmed) 5. [ Clinical Application ](#clinical-application) 6. [ Key Points for Board Exams ](#key-points-for-board-exams) 7. [ Conclusion ](#conclusion) 8. [ Frequently Asked Questions ](#blog-faqs) 9. [ References ](#references-heading) A 10-year-old boy with delayed walking, late language, academic plateau, behavioral outbursts, macrocephaly, a long face, prominent forehead, large everted ears, finger hypermobility, and hypotonia is not a routine “school failure” visit. Add a maternal uncle with significant disability, and the case stops being about isolated learning problems. It becomes a syndromic intellectual disability workup with immediate implications for the maternal family line. [\[1\]](#cite-1 "Reference [1]") Why this phenotype should push Fragile X up the list ---------------------------------------------------- The combination of **male sex**, **maternal-line family history**, **long face**, **large ears**, **hypotonia**, **joint laxity**, and relative **macrocephaly** is highly compatible with **Fragile X syndrome**. The physical phenotype may be subtle in younger children and becomes more recognizable with age, which fits a 10-year-old whose academic demands are now exposing the full neurocognitive burden. [\[2\]](#cite-2 "Reference [2]") A short differential still matters: DiagnosisWhy it stays on the list**Fragile X syndrome**Maternal family history plus connective-tissue and craniofacial clues**PTEN-related disorder**Macrocephaly with neurodevelopmental symptoms, but family pattern is less persuasive**Sotos syndrome**Prominent forehead and learning issues, but no overgrowth pattern here This is phenotype-based prioritization, not certainty; however, Fragile X is the diagnosis you should be trying to prove or exclude early. [\[1\]](#cite-1 "Reference [1]") Workup strategy: broad enough, but not indiscriminate ----------------------------------------------------- Current Canadian Paediatric Society guidance recommends **comprehensive history and examination**, plus **hearing and vision assessment**, for all children with suspected GDD/IDD. For **unexplained** GDD/IDD, **chromosomal microarray (CMA)** remains the recommended first-tier genomic test. Fragile X testing, however, is now explicitly **phenotype- and family-history driven** rather than routine for every child. In this case, targeted **FMR1 CGG repeat testing** should be sent immediately, ideally alongside CMA rather than after it. [\[1\]](#cite-1 "Reference [1]") If first-tier testing is unrevealing, ACMG supports **early exome/genome sequencing** as a first- or second-tier option in pediatric DD/ID because diagnostic yield and clinical utility are higher than a prolonged serial workup. That said, exome is **not** a substitute for Fragile X testing when suspicion is high, because **FMR1 repeat expansion analysis requires specific laboratory methods**. [\[3\]](#cite-3 "Reference [3]") Ancillary tests should be chosen because the phenotype earns them. Repeat **audiology** and **vision** testing are appropriate despite prior normal screening; CPS specifically recommends reassessment in etiologic evaluation, and follow-up hearing assessment is warranted even after a normal newborn screen. **TSH** is reasonable when newborn screening is uncertain or clinical signs suggest hypothyroidism. **Lead** testing is appropriate when pica or exposure risk exists. **CK** becomes useful when hypotonia or motor findings raise concern for dystrophinopathy. Broad metabolic panels are better reserved for **developmental regression**, **intractable seizures**, or **severe hypotonia/metabolic features**. MRI is not routine here; **focal deficits**, **microcephaly**, or **regression** would move it higher. [\[1\]](#cite-1 "Reference [1]") > **Clinical Pearl:** If the stem says “unexplained ID,” think **CMA** first. If the stem gives you a boy with long face, large ears, hypermobility, and maternal-line disability, send **FMR1 testing up front**. That exam distinction is easy to miss and clinically important. [\[1\]](#cite-1 "Reference [1]") Why the molecular diagnosis matters ----------------------------------- Fragile X syndrome results from **CGG expansion in FMR1**. **Full-mutation alleles** undergo hypermethylation, silence FMR1 transcription, and reduce **FMRP**, disrupting synaptic protein translation and plasticity. **Premutation alleles** behave differently: they are associated with excess **FMR1 mRNA** and underlie carrier conditions such as **FXPOI** and **FXTAS**. That mechanistic difference explains why an apparently unaffected female relative may still have major reproductive or later neurologic implications. [\[2\]](#cite-2 "Reference [2]") Management after Fragile X is confirmed --------------------------------------- Once FMR1 testing confirms the diagnosis, management becomes longitudinal and multidisciplinary. The child needs updated psychoeducational assessment, IEP revision, speech-language therapy, OT, and structured behavioral management. He also needs surveillance for the comorbidity clusters common in ID and Fragile X, especially **ADHD/anxiety and other behavioral symptoms**, **seizures**, **vision/hearing problems**, **sleep issues**, and **GI symptoms**. [\[2\]](#cite-2 "Reference [2]") Family counseling is equally high yield. GeneReviews notes that women with an **FMR1 premutation** have a **50% chance in each pregnancy** of transmitting an abnormal allele, and CDC notes increased risk of **FXPOI** and **FXTAS** among premutation carriers. For the sister who is planning pregnancy, this is not abstract genetics; it is immediate preconception counseling. ACOG recommends Fragile X premutation carrier screening for women with a family history of Fragile X-related disorders or intellectual disability suggestive of Fragile X who are considering pregnancy or are pregnant. [\[2\]](#cite-2 "Reference [2]") Clinical Application -------------------- In clinic, the highest-value move is **parallel processing**: send genetics, refresh hearing and vision testing, ask specifically about regression and seizures, document adaptive function, and update school supports at the same visit. Families remember the blood test, but outcomes are usually shaped more by how quickly the diagnosis is translated into therapy, surveillance, and cascade counseling for relatives. [\[1\]](#cite-1 "Reference [1]") Key Points for Board Exams -------------------------- - **CMA** is first-tier for unexplained GDD/IDD, but **FMR1 testing** should be ordered early when phenotype or family history suggests Fragile X. [\[1\]](#cite-1 "Reference [1]") - The classic clue cluster is **male sex + maternal family history + long face + large ears + hypotonia/hypermobility**. [\[2\]](#cite-2 "Reference [2]") - Do **not** anchor on an old normal sensory screen; repeat **hearing and vision** assessment in the etiologic workup. [\[1\]](#cite-1 "Reference [1]") - Reserve metabolic testing for **red flags** such as regression, seizures, or severe hypotonia/metabolic features. [\[1\]](#cite-1 "Reference [1]") - **MRI brain** is higher yield with **focal findings**, **microcephaly**, or **regression**, not isolated academic decline. [\[1\]](#cite-1 "Reference [1]") - Premutation counseling matters because carriers are at risk for **FXPOI** and **FXTAS**. [\[4\]](#cite-4 "Reference [4]") Conclusion ---------- This case rewards clinicians who recognize pattern before protocol. Broad genomics is increasingly early in DD/ID, but a child who looks like Fragile X should trigger targeted **FMR1** testing, deliberate comorbidity screening, and immediate reproductive counseling for relatives. In pediatrics, that is not just diagnosis; it is prevention for the next generation. [\[1\]](#cite-1 "Reference [1]") Frequently Asked Questions ---------------------------- ### When should I order Fragile X testing immediately rather than waiting for microarray results? Order **FMR1** testing up front when the phenotype or family history is suggestive, especially in a boy with intellectual disability, long face, large ears, hypotonia/hypermobility, macrocephaly, or maternal-line relatives with developmental disability. ### Should hearing and vision be repeated if prior screening was normal? Yes. In children with ID/GDD, current guidance supports renewed **hearing and vision assessment** during etiologic evaluation because earlier screening does not exclude later or previously missed sensory impairment. ### When is metabolic testing worth sending in a child with intellectual disability? Use it selectively when there are red flags such as **developmental regression**, **seizures**, **severe hypotonia**, or other neurologic/metabolic features. Routine broad metabolic screening has low yield in otherwise stable, nonregressive presentations. ### Why does the patient’s sister need counseling before pregnancy? If she carries an **FMR1 premutation**, she may be at risk for **FXPOI** and can transmit an abnormal allele to offspring. Preconception counseling clarifies carrier status, reproductive risk, and testing options. References (7) ------------------ 1. 1. [ Canadian Paediatric Society. Assessing children and youth with global developmental delay and intellectual developmental disorder (2025/2026). ](https://cps.ca/en/documents/position/Assessing-GDD-IDD) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ www.ncbi.nlm.nih.gov/sites/books/NBK1384 ](https://www.ncbi.nlm.nih.gov/sites/books/NBK1384/) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ Manickam K, McClain MR, Demmer LA, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an ACMG evidence-based clinical guideline. Genetics in Medicine. 2021. ](https://www.nature.com/articles/s41436-021-01242-6) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ Centers for Disease Control and Prevention. Fragile X-Associated Disorders. ](https://www.cdc.gov/fragile-x-syndrome/associated-disorders/index.html) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ Spector E, Behlmann A, Kronquist K, et al. Laboratory testing for fragile X, 2021 revision: a technical standard of the ACMG. Genetics in Medicine. 2021. ](https://www.nature.com/articles/s41436-021-01115-y) 6. 6. [ Finucane B, Abrams L, Cronister A, et al. FMR1 Disorders. GeneReviews®. NCBI Bookshelf. ](https://www.ncbi.nlm.nih.gov/books/NBK1384/) 7. 7. [ American College of Obstetricians and Gynecologists. Carrier Screening for Genetic Conditions. Committee Opinion. 2017. ](https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/03/carrier-screening-for-genetic-conditions) Study pathway Practice Pediatrics the way boards test ----------------------------------------- - Age‑specific differentials and management - Growth, development, and immunizations - Target weak areas with smart review Free 5-day trial No credit card required. [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Pediatrics ](https://mdster.com/speciality/pediatrics) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Board Review ](https://mdster.com/blog?tag=board-review) [ # Pediatrics ](https://mdster.com/blog?tag=pediatrics) [ # Fragile X Syndrome ](https://mdster.com/blog?tag=fragile-x-syndrome) [ # Intellectual Disability ](https://mdster.com/blog?tag=intellectual-disability) [ # Developmental Delay ](https://mdster.com/blog?tag=developmental-delay) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Case Discussion ----------------------- [ See all ](https://mdster.com/blog?category=case-discussion) [### Pediatric Acute Severe Asthma: ED Case Discussion 4 min read Jun 18, 2026 ](https://mdster.com/blog/pediatric-acute-severe-asthma-ed-case-discussion) [### Bronchiolitis to Pediatric Shock: PEWS, I-PASS, Resuscitation 6 min read Jun 16, 2026 ](https://mdster.com/blog/bronchiolitis-to-pediatric-shock-pews-i-pass-resuscitation) [### Suspected LVO Stroke: EMS Destination, BP, and Reperfusion 5 min read Jun 14, 2026 ](https://mdster.com/blog/suspected-lvo-stroke-ems-destination-bp-and-reperfusion) Related Posts ------------- [ ![Drug Metabolism in Liver Disease: Anesthesia Board Pearls](https://mdster.com/storage/blog/images/drug-metabolism-in-liver-disease-anesthesia-board-pearls.jpg) Medical Education ### Drug Metabolism in Liver Disease: Anesthesia Board Pearls Learn how liver disease changes anesthetic drug handling, including albumin binding, extraction ratios, clearance, and prolonged sedation risk. 5 min read 0 comments ](https://mdster.com/blog/drug-metabolism-in-liver-disease-anesthesia-board-pearls) [ ![Pediatric Acute Severe Asthma: ED Case Discussion](https://mdster.com/storage/blog/images/pediatric-acute-severe-asthma-ed-case-discussion.jpg) Case Discussion ### Pediatric Acute Severe Asthma: ED Case Discussion A board-focused pediatric asthma case covering severity classification, ED stabilization, differential diagnosis, discharge readiness, and action-plan teaching. 4 min read 0 comments ](https://mdster.com/blog/pediatric-acute-severe-asthma-ed-case-discussion) [ ![Bronchiolitis to Pediatric Shock: PEWS, I-PASS, Resuscitation](https://mdster.com/storage/blog/images/bronchiolitis-to-pediatric-shock-pews-i-pass-resuscitation.jpg) Case Discussion ### Bronchiolitis to Pediatric Shock: PEWS, I-PASS, Resuscitation Case-based review of an infant with bronchiolitis who deteriorates overnight into decompensated shock, highlighting PEWS triggers and I-PASS failures. 6 min read 0 comments ](https://mdster.com/blog/bronchiolitis-to-pediatric-shock-pews-i-pass-resuscitation) [ ![Ovarian Aging and Follicular Depletion in Menopause](https://mdster.com/storage/blog/images/ovarian-aging-and-follicular-depletion-in-menopause.jpg) Medical Education ### Ovarian Aging and Follicular Depletion in Menopause Understand ovarian aging as a follicle-depletion syndrome driving FSH rise, irregular cycles, vasomotor symptoms, and accelerated bone loss. 6 min read 0 comments ](https://mdster.com/blog/ovarian-aging-and-follicular-depletion-in-menopause) [ ![Suspected LVO Stroke: EMS Destination, BP, and Reperfusion](https://mdster.com/storage/blog/images/suspected-lvo-stroke-ems-destination-bp-and-reperfusion.jpg) Case Discussion ### Suspected LVO Stroke: EMS Destination, BP, and Reperfusion A 68-year-old with aphasia and hemiplegia forces a high-stakes EMS decision: closer thrombolysis or direct thrombectomy-capable stroke care. 5 min read 0 comments ](https://mdster.com/blog/suspected-lvo-stroke-ems-destination-bp-and-reperfusion) [ ![SLE Major Organ Involvement: Nephritis, CNS, Serositis, and Cytopenias](https://mdster.com/storage/blog/images/sle-major-organ-involvement-nephritis-cns-serositis-and-cytopenias.jpg) Medical Education ### SLE Major Organ Involvement: Nephritis, CNS, Serositis, and Cytopenias Major SLE organ disease is where missed urinalysis, misattributed psychosis, or ignored cytopenias can cost kidneys, brains, and lives. 5 min read 0 comments ](https://mdster.com/blog/sle-major-organ-involvement-nephritis-cns-serositis-and-cytopenias) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept